NASDAQ: VECT - VectivBio Holding AG

Yield per half year: 0%
Sector: Healthcare

Share chart VectivBio Holding AG

Extended chart Simple chart
Financial Markets by TradingView

About

VectivBio Holding AG, биофармацевтическая компания клинической стадии, специализируется на открытии, разработке и коммерциализации средств лечения редких заболеваний. Он разрабатывает апраглутид, синтетический пептидный аналог глюкагоноподобного пептида-2 длительного действия, который проходит III фазу клинических испытаний для лечения пациентов с синдромом короткой кишки и кишечной недостаточностью (SBS-IF), а также для SBS-IF. у пациентов с анатомией непрерывной толстой кишки. Компания была зарегистрирована в 2019 году, ее штаб-квартира находится в Базеле, Швейцария.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2021-04-08
ISIN CH1109007893
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://vectivbio.com
Цена ао 16.85
Change price per day: 0% (16.85)
Change price per week: 0% (16.85)
Change price per month: 0% (16.85)
Change price per 3 month: 0% (16.85)
Change price per half year: 0% (16.85)
Change price per year: 0% (16.85)
Change price per 3 year: +243.88% (4.9)
Change price per 5 year: 0% (16.85)
Change price per 10 year: 0% (16.85)
Change price per year to date: 0% (16.85)
All parameters

Underestimation

Title Value Grade
P/S 14.17 1
P/BV 1.82 8
P/E 0 0
EV/EBITDA -2.21 0
Total: 4.5

Efficiency

Title Value Grade
ROA, % -48.18 0
ROE, % -56.92 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.1316 10
Total: 9

Growth impulse

Title Value Grade
Yield Revenue, % -5.27 0
Yield Ebitda, % 198.34 10
Yield EPS, % 219.8 10
Total: 8
More

Institutions Volume Share, %
CHI Advisors LLC 5255484 8.38
Orbimed Advisors LLC. 5156561 8.22
Citadel Advisors Llc 3967537 6.32
Eventide Asset Management LLC 3675644 5.86
Novo Holdings A/S 3610461 5.75
Tcg Crossover Management, Llc 3113600 4.96
Bpifrance SA 2806217 4.47
Cormorant Asset Management, LP 2536617 4.04
Vivo Capital, LLC 2333300 3.72
VR Adviser, LLC 1866000 2.97



Head Job title Payment Year of birth
Dr. Luca Santarelli M.D. Founder, CEO & Director N/A 1969 (56 years)
Dr. Alain Bernard Ph.D. Chief Technology Officer N/A 1957 (68 years)
Mr. Scott Applebaum Chief Legal Officer & Corp. Sec. N/A 1967 (58 years)
Dr. Sarah Holland Ph.D. Chief Bus. Officer N/A 1963 (62 years)
Dr. Omar Khwaja M.D., Ph.D. Chief Medical Officer N/A 1971 (54 years)
Dr. Christian Meyer M.D., Ph.D. Chief Operating Officer N/A 1967 (58 years)
Mr. Patrick Malloy Sr. VP of Investor Relations & Strategic Communications N/A
Mr. Michael Steininger Sr. VP & Head of HR N/A
Mr. Kevin Harris M.B.A. Chief Commercial Officer N/A 1971 (54 years)
Ms. Claudia D'Augusta Ph.D. Chief Financial Officer 1970 (55 years)

Address: Switzerland, Basel, Aeschenvorstadt 36 - open in Google maps, open in Yandex maps
Website: https://vectivbio.com